SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI United States of America flag

SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: LantusSyringeDefinition

Page standards status: Informative

Generated Narrative: MedicinalProductDefinition LantusSyringeDefinition

identifier: National drug codes/0088-5020

route: SUBCUTANEOUS

MarketingStatuses

-StatusDateRange
*active2017-06-04 --> (ongoing)

name

productName: Lantus Solostar

type: Proprietary Name

name

productName: insulin glargine

type: Generic Name (Non-Proprietary)

operation

Types

-Concept
*ANALYSIS

organization: Organization Sanofi-Aventis Deutschland GmbH

operation

Types

-Concept
*API MANUFACTURE

organization: Organization Sanofi-Aventis Deutschland GmbH

operation

Types

-Concept
*LABEL

organization: Organization Sanofi-Aventis Deutschland GmbH

operation

Types

-Concept
*MANUFACTURE

organization: Organization Sanofi-Aventis Deutschland GmbH

operation

Types

-Concept
*PACK

organization: Organization Sanofi-Aventis Deutschland GmbH